Literature DB >> 8727941

Chronological changes in the complement system in sepsis.

H Nakae1, S Endo, K Inada, M Yoshida.   

Abstract

The time courses of serum complement levels and the severity of sepsis were compared in two groups of septic patients, one in which the patients survived (surviving group) and one in which they did not (nonsurviving group). The components of the complement system, namely, C3a, C4a, C5a, CH50, C3, C4, and C5, were measured at several points in time after the diagnosis of sepsis had been established. A 2-antibody radioimmunoassay was used to measure C3a, C4a, and C5a; the latex agglutination test was used to measure C3 and C4; nephelometry was used to measure C5; and Meyer's 50% hemolysis method was used to measure CH50. Following the diagnosis of sepsis, the levels of CH50, C3, and C4 were significantly lower in the nonsurviving than the surviving group, while the levels of C3a and C4a were significantly higher in the nonsurviving than the surviving group. The C5a levels were significantly higher in the nonsurviving than the surviving group, although no significant intergroup differences were subsequently noted. These results suggest that the serum levels of C3a, C4a, C5a, CH50, C3, and C4 could serve as indices of the severity of sepsis. Thus, monitoring the complement system may be useful for predicting the outcome of patients with sepsis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8727941     DOI: 10.1007/BF00311579

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  14 in total

1.  Complement activation in septic shock patients.

Authors:  C L Sprung; D R Schultz; E Marcial; P V Caralis; M A Gelbard; P I Arnold; W M Long
Journal:  Crit Care Med       Date:  1986-06       Impact factor: 7.598

2.  Serum complement levels and severity of sepsis.

Authors:  H Nakae; S Endo; K Inada; T Takakuwa; T Kasai; M Yoshida
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1994-05

3.  Quantitation of human complement fragment C4ai in physiological fluids by competitive inhibition radioimmune assay.

Authors:  J P Gorski
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

4.  Serum complement levels in bacteremia due to gram-negative organisms.

Authors:  W R McCabe
Journal:  N Engl J Med       Date:  1973-01-04       Impact factor: 91.245

5.  C5a-mediated release of interleukin 6 by human monocytes.

Authors:  W Scholz; M R McClurg; G J Cardenas; M Smith; D J Noonan; T E Hugli; E L Morgan
Journal:  Clin Immunol Immunopathol       Date:  1990-11

6.  Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages.

Authors:  J M Cavaillon; C Fitting; N Haeffner-Cavaillon
Journal:  Eur J Immunol       Date:  1990-02       Impact factor: 5.532

7.  Consumptive opsoninopathy: possible pathogenesis in lethal and opportunistic infections.

Authors:  J W Alexander; M A McClellan; C K Ogle; J D Ogle
Journal:  Ann Surg       Date:  1976-12       Impact factor: 12.969

8.  Interactions of the classical and alternate complement pathway with endotoxin lipopolysaccharide. Effect on platelets and blood coagulation.

Authors:  M A Kane; J E May; M M Frank
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

9.  Complement activation in septic shock due to gram-negative and gram-positive bacteria.

Authors:  C León; M J Rodrigo; A Tomasa; M T Gallart; F J Latorre; J Rius; J Brugués
Journal:  Crit Care Med       Date:  1982-05       Impact factor: 7.598

10.  Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN).

Authors:  R Huey; T E Hugli
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

View more
  27 in total

1.  Functions of the complement components C3 and C5 during sepsis.

Authors:  Michael A Flierl; Daniel Rittirsch; Brian A Nadeau; Danielle E Day; Firas S Zetoune; J Vidya Sarma; Markus S Huber-Lang; Peter A Ward
Journal:  FASEB J       Date:  2008-06-27       Impact factor: 5.191

2.  Evidence for complement activation in the amniotic fluid of women with spontaneous preterm labor and intra-amniotic infection.

Authors:  Eleazar Soto; Roberto Romero; Karina Richani; Bo H Yoon; Tinnakorn Chaiworapongsa; Edi Vaisbuch; Pooja Mittal; Offer Erez; Francesca Gotsch; Moshe Mazor; Juan P Kusanovic
Journal:  J Matern Fetal Neonatal Med       Date:  2009-11

3.  Anaphylatoxins in preterm and term labor.

Authors:  Eleazar Soto; Roberto Romero; Karina Richani; Jimmy Espinoza; Jyh Kae Nien; Tinnakorn Chaiworapongsa; Joaquin Santolaya-Forgas; Samuel S Edwin; Moshe Mazor
Journal:  J Perinat Med       Date:  2005       Impact factor: 1.901

4.  Fc microparticles can modulate the physical extent and magnitude of complement activity.

Authors:  Brandon Alexander Holt; Michael C Bellavia; Daniel Potter; David White; Sean R Stowell; Todd Sulchek
Journal:  Biomater Sci       Date:  2017-02-28       Impact factor: 6.843

5.  Increased concentration of the complement split product C5a in acute pyelonephritis during pregnancy.

Authors:  Eleazar Soto; Karina Richani; Roberto Romero; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Jyh Kae Nien; Samuel Edwin; Yeon Mee Kim; Joon-Seok Hong; Luis Goncalves; Moshe Mazor
Journal:  J Matern Fetal Neonatal Med       Date:  2005-04

6.  Normal pregnancy is characterized by systemic activation of the complement system.

Authors:  Karina Richani; Eleazar Soto; Roberto Romero; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Jyh Kae Nien; Samuel Edwin; Yeon Mee Kim; Joon-Seok Hong; Moshe Mazor
Journal:  J Matern Fetal Neonatal Med       Date:  2005-04

7.  Anti-c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis.

Authors:  Ines J Laudes; Jeffrey C Chu; Sujata Sikranth; Markus Huber-Lang; Ren-Feng Guo; Niels Riedemann; J Vidya Sarma; Alvin H Schmaier; Peter A Ward
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

8.  Complement activation in emergency department patients with severe sepsis.

Authors:  John G Younger; David O Bracho; Hangyul M Chung-Esaki; Moonseok Lee; Gurpreet K Rana; Ananda Sen; Alan E Jones
Journal:  Acad Emerg Med       Date:  2010-04       Impact factor: 3.451

9.  Disruption of the C5a receptor gene increases resistance to acute Gram-negative bacteremia and endotoxic shock: opposing roles of C3a and C5a.

Authors:  Travis J Hollmann; Stacey L Mueller-Ortiz; Michael C Braun; Rick A Wetsel
Journal:  Mol Immunol       Date:  2007-12-11       Impact factor: 4.407

10.  Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis.

Authors:  Michael A Flierl; Philip F Stahel; Daniel Rittirsch; Markus Huber-Lang; Andreas D Niederbichler; L Marco Hoesel; Basel M Touban; Steven J Morgan; Wade R Smith; Peter A Ward; Kyros Ipaktchi
Journal:  Crit Care       Date:  2009-02-06       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.